# Hyland Therapeutic Div., Travenol Laboratories

- Location (FDA's records): Mchenry, IL
- FDA decisions: 44 (1976–1982): 44 510(k) clearances
- Product codes: JIX (3), LGO (2), DAK (2), GFO (2), DIF (2), CZJ (1), DER (1), JZH (1), JJY (1), CEE (1), DHR (1), DFT (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K820835: Alumina Silica-Activated Partial Throm (Apr 26, 1982)
- K820192: Haemophilus Influenzae Type B Antiserum (Mar 11, 1982)
- K812220: Nephelometric Solid Turbidity Standard (Aug 18, 1981)
- K810078: Q-Pak Therapeutic Drug Monit. Control S (Feb 2, 1981)
- K810077: Omega Therapeutic Drug Monit. Control S. (Jan 28, 1981)
- K802610: Alert a,HDL-Apoliporotein a, Test Kit (Jan 5, 1981)
- K791113: Low Ionic Strength Solution (Liss) (Jun 28, 1979)
- K790249: Test Cells (May 16, 1979)

Source page: https://510kreport.com/company/hyland-therapeutic-div-travenol-laboratories